Publications: Prof Ranjit Manchanda
Oxley S, Ahmed S, Baxter K, Blake D, Braden V, Brincat MR, Bryan S, Dilley J et al.
(
2024
)
.
Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
.
Int J Gynecol Cancer
vol.
34
,
(
11
)
1768
-
1774
.
Fierheller C, Sarig K, Oxley S, Kalra A, Sobocan M, Sideris M, Gootzen T, Ferris M et al.
(
2024
)
.
BRCA awareness and testing experience in the UK Jewish population: A qualitative study
.
Gynecologic Oncology
.
vol.
190
,
s162
-
s163
.
Fierheller C, Gootzen T, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A et al.
(
2024
)
.
BRCA1 and BRCA2 information provision online: An occasion for improvement
.
Gynecologic Oncology
.
vol.
190
,
Manchanda R, Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J et al.
(
2024
)
.
Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Gynecologic Oncology
.
vol.
190
,
s159
-
s160
.
Fierheller C, Sun L, Wei X, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
Population-based BRCA1 and BRCA2 genetic testing is cost-effective in Canada
.
Gynecologic Oncology
.
vol.
190
,
Bizzarri N, Querleu D, Ramirez PT, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Salehi S et al.
(
2024
)
.
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
.
European Journal of Cancer
vol.
211
,
Article
114310
,
114310
-
114310
.
Kalra A, Ganesan S, Sia J, Papalois K-B, Pandya A, Xiong R, Wei X, Oxley S et al.
(
2024
)
.
EV186/#1233 Patient-related outcomes of mainstreaming genetic testing – a systematic review and meta-analysis
.
Conference:
E-Poster Viewing Abstractsa179
-
a180
.
Taylor A, Clement K, Hillard T, Sassarini J, Ratnavelu N, Baker-Rand H, Bowen R, Davies MC et al.
(
2024
)
.
British Gynaecological Cancer Society and British Menopause Society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer
.
Post Reproductive Health
Ng ZY, Manchanda R, Cibula D
(
2024
)
.
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study
.
Gynecologic Oncology
Torr B, Jones C, Kavanaugh G, Hamill M, Allen S, Choi S, Garrett A, Valganon-Petrizan M et al.
(
2024
)
.
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial
.
British Journal of Cancer
vol.
131
,
(
9
)
1506
-
1515
.
Sundar S, Agarwal R, Davenport C, Scandrett K, Johnson S, Sengupta P, Selvi-Vikram R, Kwong FL et al.
(
2024
)
.
Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study
.
The Lancet Oncology
vol.
25
,
(
10
)
1371
-
1386
.
Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
Economic Evaluation of Population-Based <i>BRCA1</i> and <i>BRCA2</i> Testing in Canada
.
JAMA Network Open
vol.
7
,
(
9
)
e2432725
-
e2432725
.
Leung EY, Nicum S, Morrison J, Brenton JD, Funingana I-G, Morgan RD, Ghaem-Maghami S, Miles T et al.
(
2024
)
.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom
.
International Journal of Gynecological Cancer
vol.
34
,
(
9
)
1334
-
1343
.
Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, Banerjee S, Bowen R et al.
(
2024
)
.
British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024
.
European Journal of Obstetrics & Gynecology and Reproductive Biology
vol.
300
,
69
-
123
.
Kwong FLA, Kristunas C, Davenport C, Deeks J, Mallett S, Agarwal R, Kehoe S, Timmerman D et al.
(
2024
)
.
Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer
.
International Journal of Gynecological Cancer
Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J, focusgroup CS, Hermens RPMG et al.
(
2024
)
.
Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
131
,
(
13
)
1851
-
1861
.
Gootzen TA, Kalra A, Sarig K, Sobočan M, Oxley SG, Dworschak N, Georgiannakis A, Glynou S et al.
(
2024
)
.
Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis
.
Cancers
vol.
16
,
(
13
)
Sarig K, Oxley S, Kalra A, Sobocan M, Fierheller CT, Sideris M, Gootzen T, Ferris M et al.
(
2024
)
.
BRCA awareness and testing experience in the UK Jewish population: a qualitative study
.
J Med Genet
vol.
61
,
(
7
)
716
-
725
.
Manchanda R, Sun L, Sobocan M, Rodriguez IV, Wei X, Kalra A, Oxley S, Sideris M et al.
(
2024
)
.
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer
.
Journal of the National Comprehensive Cancer Network
vol.
22
,
(
2D
)
Joy JD, Malacrida B, Laforêts F, Kotantaki P, Maniati E, Manchanda R, Annibaldi A, Hopkins S et al.
(
2024
)
.
Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity
.
Cancer Research
vol.
84
,
(
15
)
2432
-
2449
.
Slade E, Berg L, Dworzynski K, Manchanda R
(
2024
)
.
Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance
.
The BMJ
vol.
385
,
Newton C, Graham R, Liberale V, Burnell M, Menon U, Mould T, Olaitan A, Macdonald N et al.
(
2024
)
.
Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer
.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
vol.
44
,
(
1
)
Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Fierheller C, Kalra A, Sia J, Miller RE et al.
(
2024
)
.
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study
.
BJOG
vol.
131
,
(
6
)
848
-
857
.
Kwong FL, Kristunas C, Davenport C, Aggarwal R, Deeks J, Mallett S, Kehoe S, Timmerman D et al.
(
2024
)
.
Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
131
,
(
10
)
1400
-
1410
.
Oxley SG, Wei X, Sideris M, Blyuss O, Kalra A, Sia JJY, Ganesan S, Fierheller CT et al.
(
2024
)
.
Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D
.
Cancers
vol.
16
,
(
7
)
1358
-
1358
.
Elorbany S, Berlato C, Carnevalli L, Barry S, Maniati E, Wang J, Manchanda R, Kzhyshkowska J et al.
(
2024
)
.
Abstract 6553: Targeting macrophages and regulatory T cells improves response to chemotherapy in high-grade serous ovarian cancer
.
Cancer Research
vol.
84
,
(
6_Supplement
)
6553
-
6553
.
Manchanda R, Evans DG, Antoniou AC, Brentnall A
(
2024
)
.
Penetrance estimates of hereditary cancers in a population setting using UK Biobank data
.
BJC Reports
vol.
2
,
(
1
)
Sideris M, Brincat MR, Blyuss O, Enumula M, Cyclewala S, Oxley S, Sia J, Kalra A et al.
(
2024
)
.
1033 Validation of P-POSSUM scale in ovarian cancer (OC) cytoreductive surgery
.
Conference:
Poster and E-Postersa391.3
-
a3a392
.
Gootzen TA, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A, Glynou S et al.
(
2024
)
.
405 Analysis of BRCA1 and BRCA2 information provision online
.
Conference:
Poster and E-Postersa448
-
a449
.
Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation
.
Conference:
Young Investigator Sessiona52
-
a53
.
Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Conference:
Oral Sessionsa40
-
a41
.
Kalra A, Gootzen TA, Fierheller CT, Sarig K, Pan Y, Parmar A, Papalois K-B, Samuels AJ et al.
(
2024
)
.
461 HBOC and lynch syndrome: ai-powered multi-platform analysis of social media activity
.
Conference:
Poster and E-Postersa259.1
-
a2a259
.
Oxley S, Sia J, Samuels A, Kalra A, Wei X, Fierheller CT, Sideris M, Glenn Mccluggage W et al.
(
2024
)
.
583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study
.
Conference:
Poster and E-Postersa454.1
-
a4a454
.
Oxley S, Wei X, Sideris M, Blyuss O, Kalra A, Sia J, Ganesan S, Fierheller CT et al.
(
2024
)
.
948 EQ-5D utility scores for risk-reducing mastectomy and risk-reducing salpingo-oophorectomy: mapping from SF-12 and SF-36
.
Conference:
Poster and E-Postersa460.1
-
a4a460
.
Joy JD, Malacrida B, Laforets F, Kotantaki P, Maniati E, Manchanda R, Hopkins S, Garrobo-Calleja I et al.
(
2024
)
.
Abstract B079: Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR-T cell activity
.
Cancer Research
vol.
84
,
(
5_Supplement_2
)
b079
-
b079
.
Malacrida B, Elorbany S, Maniati E, Bryan-Ravenscroft R, Skingsley SLP, Laforets F, Manchanda R, Balkwill FR
(
2024
)
.
Abstract PR-009: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer using human multicellular in vitro models
.
Cancer Research
vol.
84
,
(
5_Supplement_2
)
Sideris M, Menon U, Manchanda R
(
2024
)
.
Screening and prevention of ovarian cancer
.
The Medical Journal of Australia
vol.
220
,
(
5
)
264
-
274
.
Wei X, Sun L, Slade E, Fierheller CT, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
.
JAMA network open
vol.
7
,
(
2
)
Lakhiani A, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al.
(
2023
)
.
Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study
.
Cancers
vol.
16
,
(
1
)
Wei X, Sun L, Slade E, Oxley S, Kalra A, Sia J, Sideris M, Fierheller C et al.
(
2023
)
.
EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer
.
Value in Health
.
vol.
26
,
s183
-
s184
.
Dilley J, Gentry-Maharaj A, Ryan A, Burnell M, Manchanda R, Kalsi J, Singh N, Woolas R et al.
(
2023
)
.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
.
Gynecol Oncol
vol.
179
,
123
-
130
.
Gaba F, Blyuss O, Chandrasekaran D, Bizzarri N, Refky B, Barton D, Ind T, Nobbenhuis M et al.
(
2023
)
.
Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis
.
Diagnostics
vol.
13
,
(
22
)
Lacaze P, Marquina C, Tiller J, Brotchie A, Kang Y-J, Merritt MA, Green RC, Watts GF et al.
(
2023
)
.
Combined population genomic screening for three high-risk conditions in Australia: a modelling study
.
EClinicalMedicine
vol.
66
,
Torr B, Choi S, Allen S, Hamill M, Kavanaugh G, MacMahon S, Poyastro-Pearson E, Yuan L et al.
(
2023
)
.
LBA101 BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast cancer
.
Annals of Oncology
vol.
34
,
Wei X, Oxley S, Sideris M, Legood R, Manchanda R
(
2023
)
.
Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: response
.
American Journal of Obstetrics and Gynecology
vol.
230
,
(
2
)
274
-
275
.
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Singh N, Manchanda R, Kalsi JK, Woolas R et al.
(
2023
)
.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial
.
The Lancet Oncology
vol.
24
,
(
9
)
1018
-
1028
.
Bizzarri N, Querleu D, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Salehi S, Ayhan A et al.
(
2023
)
.
Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
.
American Journal of Obstetrics and Gynecology
vol.
229
,
(
4
)
428.e1
-
428.e12
.
Pillai D, Narayan J, Gentry-Maharaj A, Deo S, Vijaykumar DK, Mukherjee P, Wadhwa N, Bhasin A et al.
(
2023
)
.
Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India
.
Cancers
vol.
15
,
(
11
)
Morgan RD, Clamp AR, Barnes BM, Timms K, Schlecht H, Yarram-Smith L, Wallis Y, Valganon-Petrizan M et al.
(
2023
)
.
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study
.
International Journal of Gynecological Cancer
vol.
33
,
(
8
)
1253
-
1259
.
Elorbany S, Berlato C, Carnevalli L, Maniati E, Wang J, Barry S, Manchanda R, Kzhyshkowska J et al.
(
2023
)
.
Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer
.
Cancer Research
vol.
83
,
(
8_Supplement
)
lb195
-
lb195
.
Wei X, Oxley S, Sideris M, Kalra A, Brentnall A, Sun L, Yang L, Legood R et al.
(
2023
)
.
Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
.
American Journal of Obstetrics and Gynecology
vol.
229
,
(
4
)
388
-
409.e4
.
Malacrida B, Elorbany S, Maniati E, Laforets F, Manchanda R, Balkwill FR
(
2023
)
.
Abstract 4551: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer: understanding the contribution of malignant cells
.
Cancer Research
vol.
83
,
(
7_Supplement
)
4551
-
4551
.
Laforets F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F
(
2023
)
.
Abstract 5913: Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments
.
Cancer Research
vol.
83
,
(
7_Supplement
)
5913
-
5913
.
Kotantaki P, Laforêts F, Maniati E, Berlato C, Malliouri A, Devlin MJ, Malacrida B, Elorbany S et al.
(
2023
)
.
Abstract 5957: Chemotherapy-induced extracellular matrix remodeling in HGSOC
.
Cancer Research
vol.
83
,
(
7_Supplement
)
5957
-
5957
.
Laforêts F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F
(
2023
)
.
Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments
.
iScience
vol.
26
,
(
4
)
Gaba F, Blyuss O, Tan A, Munblit D, Oxley S, Khan K, Legood R, Manchanda R
(
2023
)
.
Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
.
Cancers
vol.
15
,
(
5
)
Oxley S, Wei X, Sideris M, Manchanda R
(
2023
)
.
Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer
.
Screening and Risk Reduction Strategies for Breast Cancer
,
Springer Nature
Oxley S, Kalra A, Sideris M, Itzkowitz N, Evans O, Atakpa EC, Brentnall AR, Dworschak N et al.
(
2023
)
.
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK
.
Cancers
vol.
15
,
(
4
)
Lacaze P, Manchanda R, Green RC
(
2023
)
.
Prioritizing the detection of rare pathogenic variants in population screening
.
Nature Reviews Genetics
vol.
24
,
(
4
)
205
-
206
.
Wei X, Oxley S, Sideris M, Kalra A, Sun L, Yang L, Legood R, Manchanda R
(
2022
)
.
Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review
.
Cancers
vol.
14
,
(
24
)
Yong N, Cooper N, Yorke S, Baran C, Khan K, Tan A, Sideris M, Iliodromiti S et al.
(
2022
)
.
Variation in outcome reporting in studies of fertility‐sparing surgery for cervical cancer: A systematic review
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
130
,
(
2
)
163
-
175
.
Grube M, Neilson A, Plante M, Brummel K, Kroon CD, Schochter F, Sideris M, Heitz F et al.
(
2022
)
.
O031/#777 Lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease: results from the leopard trial
.
Conference:
Focused Plenary Abstractsa20.1
-
a2a20
.
Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Falconer H, Querleu D, Ayhan A et al.
(
2022
)
.
Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
.
Obstetrics and Gynecology
vol.
141
,
(
1
)
207
-
214
.
Oxley S, Xiong R, Wei X, Kalra A, Sideris M, Legood R, Manchanda R
(
2022
)
.
Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review
.
Cancers
vol.
14
,
(
23
)
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, Antoniou AC et al.
(
2022
)
.
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
.
Journal of Medical Genetics
vol.
60
,
(
5
)
417
-
429
.
Gaba F, Ash K, Blyuss O, Bizzarri N, Kamfwa P, Ramirez PT, Kotsopoulos IC, Chandrasekaran D et al.
(
2022
)
.
Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)
.
International Journal of Gynecologic Cancer
vol.
32
,
(
12
)
1606
-
1610
.
Philpott S, Raikou M, Manchanda R, Lockley M, Singh N, Scott M, Evans DG, Adlard J et al.
(
2022
)
.
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
.
Journal of Medical Genetics
vol.
60
,
(
5
)
440
-
449
.
Wei X, Oxley S, Sideris M, Kalra A, Legood R, Manchanda R
(
2022
)
.
2022-RA-1270-ESGO Quality of Life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis
.
Conference:
Prevention of gynaecologic cancera383.1
-
a3a383
.
Wei X, Oxley S, Sideris M, Kalra A, Legood R, Manchanda R
(
2022
)
.
2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review
.
Conference:
Prevention of gynaecologic cancera383.2
-
a3a384
.
Bizzarri N, Dostálek L, Lonkhuijzen LR, Giannarelli D, Lopez A, Falconer H, Querleu D, Ayhan A et al.
(
2022
)
.
2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study
.
Conference:
Cervical cancera52.2
-
a5a53
.
Gaba F, Blyuss O, Tan A, Chandrasekaran D, Munblit D, Legood R, Khan K, Manchanda R
(
2022
)
.
2022-RA-1390-ESGO Meta-analysis of breast cancer risk and breast cancer specific mortality following risk reducing salpingo-oophorectomy in BRCA carriers
.
Conference:
Prevention of gynaecologic cancera385.1
-
a3a385
.
Yong N, Cooper N, Yorke S, Baran C, Khan K, Tan A, Sideris M, Iliodromiti S et al.
(
2022
)
.
2022-RA-1407-ESGO Variation in outcome reporting in studies of fertility sparing surgery for cervical cancer: a systematic review
.
Conference:
Fertility/Pregnancya179.2
-
a1a180
.
Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Miller R, Mills-Baldock T, Crusz S, Sun L et al.
(
2022
)
.
2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer
.
Conference:
Vaginal and vulvar cancera463.1
-
a4a463
.
Burnell M, Gaba F, Sideris M, Sobocan M, Rakshit R, Sanderson S, Loggenberg K, Gessler S et al.
(
2022
)
.
2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes
.
Conference:
Quality of life after treatmenta402.1
-
a4a402
.
Cummins C, Kumar S, Long J, Balega J, Broadhead T, Duncan T, Edmondson RJ, Fotopoulou C et al.
(
2022
)
.
Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study
.
Cancers
vol.
14
,
(
18
)
Van der Kolk WL, Van der Zee AGJ, Slomovitz BM, Baldwin PJW, Van Doorn HC, De Hullu JA, Van der Velden J, Gaarenstroom KN et al.
(
2022
)
.
Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe
.
Gynecologic Oncology
vol.
167
,
(
1
)
3
-
10
.
Sun L, Wei X, Manchanda R, Legood R, Yang L
(
2022
)
.
Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control
.
China CDC Wkly
Manchanda R, Sideris M
(
2022
)
.
Population based genetic testing for cancer susceptibility genes: quo vadis
.
BJOG: An International Journal of Obstetrics & Gynaecology
Torr B, Jones C, Choi S, Allen S, Kavanaugh G, Hamill M, Garrett A, MacMahon S et al.
(
2022
)
.
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot
.
Journal of Medical Genetics
vol.
59
,
(
12
)
1179
-
1188
.
Burnell M, Gaba F, Sobocan M, Desai R, Sanderson S, Loggenberg K, Gessler S, Side L et al.
(
2022
)
.
Randomised trial of population based BRCA testing in Ashkenazi Jews: Long term secondary lifestyle behavioural outcomes
.
BJOG: An International Journal of Obstetrics & Gynaecology
Tindale LC, Zhantuyakova A, Lam S, Woo M, Kwon JS, Hanley GE, Knoppers B, Schrader KA et al.
(
2022
)
.
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention
.
Current Oncology
vol.
29
,
(
7
)
4632
-
4646
.
Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera K, Kristiansen M, Leavy OC et al.
(
2022
)
.
The DNA methylome of cervical cells can predict the presence of ovarian cancer
.
Nature Communications
vol.
13
,
(
1
)
Kalra A, Sobocan M, Reisel D, Manchanda R
(
2022
)
.
Role of Genetics in Gynaecological Cancers
.
Gynecological Oncology
,
Springer Nature
Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, Antoniou A, Side L et al.
(
2022
)
.
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews
.
Diagnostics
vol.
12
,
(
5
)
Sun L, Cui B, Wei X, Sadique Z, Yang L, Manchanda R, Legood R
(
2022
)
.
Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China
.
Cancers
vol.
14
,
(
7
)
Taylor A, Sundar SS, Bowen R, Clayton R, Coleridge S, Fotopoulou C, Ghaem-Maghami S, Ledermann J et al.
(
2022
)
.
British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic
.
Obstetrical & Gynecological Survey
vol.
77
,
(
3
)
156
-
157
.
Manchanda R
(
2022
)
.
Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer
.
Editors:
Manchanda, R
,
MDPI
Sundar S, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al.
(
2022
)
.
Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
129
,
(
7
)
1122
-
1132
.
Manchanda R
(
2022
)
.
Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”
.
Cancers
vol.
14
,
(
2
)
Kriplani D, Olivar AA, Tchrakian N, Butcher D, Casey L, Crook JA, Deo N, Dilley J et al.
(
2022
)
.
Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting
.
Int J Gynecol Pathol
vol.
41
,
(
1
)
20
-
27
.
Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Scambia G, Ayhan A et al.
(
2021
)
.
Post-recurrence survival in patients with cervical cancer
.
Gynecologic Oncology
vol.
164
,
(
2
)
362
-
369
.
(
2021
)
.
Correction: xBritish Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom
.
International Journal of Gynecological Cancer
vol.
31
,
(
12
)
1619
-
1619
.
Lee A, Yang X, Tyrer J, Gentry-Maharaj A, Ryan A, Mavaddat N, Cunningham AP, Carver T et al.
(
2021
)
.
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors
.
Journal of Medical Genetics
vol.
59
,
(
7
)
632
-
643
.
Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R, Sanderson S, Brady A et al.
(
2021
)
.
Jewish cultural and religious factors and uptake of population‐based BRCA testing across denominations: a cohort study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
129
,
(
6
)
959
-
968
.
Taylor A, Sundar SS, Bowen R, Clayton R, Coleridge S, Fotopoulou C, Ghaem-Maghami S, Ledermann J et al.
(
2021
)
.
British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic
.
International Journal of Gynecological Cancer
vol.
32
,
(
1
)
9
-
14
.
Philpott S, Raikou M, Manchanda R, Evans G, Edmondson R, Menon U, Ahmed M, Woodward E et al.
(
2021
)
.
423 Results of the avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance program for BRCA mutation-carriers
.
International Journal of Gynecological Cancer
vol.
31
,
(
Suppl 3
)
a373
-
a374
.
Manchanda R, Oxley S, Ghaem-Maghami S, Sundar S
(
2021
)
.
COVID-19 and the impact on gynecologic cancer care
.
International Journal of Gynecology and Obstetrics
Manchanda R, Gaba F, Talaulikar V, Pundir J, Gessler S, Davies M, Menon U, College of Obstetricians and Gynaecologists OBOTR
(
2021
)
.
Risk‐Reducing Salpingo‐Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
129
,
(
1
)
e16
-
e34
.
Taylor J, Burnell M, Ryan A, Karpinskyj C, Kalsi J, Taylor H, Apostolidou S, Sharma A et al.
(
2021
)
.
Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
129
,
(
1
)
110
-
118
.
Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Fagotti A, Manchanda R et al.
(
2021
)
.
The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer
.
European Journal of Cancer
vol.
158
,
111
-
122
.
Sundar S, Cummins C, Balega J, Broadhead T, Duncan T, Edmondson R, Fotopoulou C, Kolomainen D et al.
(
2021
)
.
718 Investigating impact of ultra-radical surgery in advanced ovarian cancer using population level data linked to the SOCQER 2 multicentre study
.
Conference:
Ovarian cancera264
-
a265
.
Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R, Sanderson S, Brady A et al.
(
2021
)
.
874 Uptake of population based BRCA-testing across Jewish denominations and affect of cultural and religious factors: a cohort study
.
International Journal of Gynecological Cancer
.
Conference:
Prevention of gynaecologic cancer
vol.
31
,
a316
-
a316
.
Van Lonkhuijzen L, Dostalek L, Jarkovsky J, Lopez A, Falconer H, Scambia G, Ayhan A, Kim S et al.
(
2021
)
.
942 Survival after recurrence in early-stage cervical cancer patients
.
International Journal of Gynecological Cancer
.
Conference:
Cervical cancer
vol.
31
,
a53
-
a55
.
Cibula D, Jarkovsky J, Van Lonkhuijzen L, Falconer H, Fagotti A, Ayhan A, Kim S, Ortiz DI et al.
(
2021
)
.
960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients
.
International Journal of Gynecological Cancer
.
Conference:
Cervical cancer
vol.
31
,
a57
-
a59
.
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan Y, Saiz A, Razumova Z, Zalewski K et al.
(
2021
)
.
984 Impact of SARS-CoV-2 on training and mental wellbeing of surgical gynaecological oncology trainees
.
International Journal of Gynecological Cancer
.
Conference:
Miscellaneous
vol.
31
,
a169
-
a169
.
Rockall AG, Barwick TD, Wilson W, Singh N, Bharwani N, Sohaib A, Nobbenhuis M, Warbey V et al.
(
2021
)
.
DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA
.
Clinical Cancer Researchclincanres.1834.2021
-
clincanres.1834.2021
.
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan Y-LL, Saiz A, Razumova Z, Zalewski K et al.
(
2021
)
.
Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees
.
Int J Gynecol Cancer
vol.
31
,
(
9
)
1268
-
1277
.
Chandrasekaran D, Sobocan M, Blyuss O, Miller RE, Evans O, Crusz SM, Mills-Baldock T, Sun L et al.
(
2021
)
.
Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: Signpost study
.
Cancers
vol.
13
,
(
17
)
Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J et al.
(
2021
)
.
Ovarian Cancer Population Screening and Mortality After Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial
.
Obstetrical & Gynecological Survey
vol.
76
,
(
9
)
537
-
538
.
Reisel D, Baran C, Manchanda R
(
2021
)
.
Preventive population genomics- the model of BRCA related cancers
.
Advances in Genetics
Oonk MH, Slomovitz B, Baldwin P, Vergote I, Sharma A, Manchanda R
(
2021
)
.
Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II
.
Journal of Clinical Oncology
Mariño IP, Vázquez MA, Blyuss O, Ryan A, Gentry-Maharaj A, Kalsi J, Manchanda R, Jacobs I et al.
(
2021
)
.
Computational learning methods for early detection of ovarian cancer
.
Conference:
Emerging Topics in Artificial Intelligence (ETAI) 2021
Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J et al.
(
2021
)
.
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
.
The Lancet
vol.
397
,
(
10290
)
2182
-
2193
.
Gaba F, Goyal S, Marks D, Chandrasekaran D, Evans O, Robbani S, Tyson C, Legood R et al.
(
2021
)
.
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
.
Journal of Medical Genetics
vol.
59
,
(
2
)
122
-
132
.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.
(
2021
)
.
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448
.
Gynecologic Oncology
vol.
161
,
(
1
)
328
-
329
.
Sundar S, Manchanda R, Gourley C, George A, Wallace A, Balega J, Williams S, Wallis Y et al.
(
2021
)
.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom
.
Int J Gynecol Cancer
vol.
31
,
(
2
)
272
-
278
.
Phadnis S, Selek S, Farrag A, Zachou G, Chandrasekaran D, Brockbank E, Lawrence A, Manchanda R et al.
(
2021
)
.
Cytoreduction surgery for recurrent ovarian cancer: cohort study from UK tertiary centre
.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
.
vol.
128
,
58
-
59
.
Gaba F, Blyuss O, Sanderson S, Antoniou A, Kalsi J, Wallace A, Menon U, Legood R et al.
(
2020
)
.
401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention
.
Conference:
Prevention of gynaecologic cancera93.1
-
a9a93
.
Gaba F, Blyuss O, Legood R, Izatt L, Tripathi V, Ragupathy K, Crawfordd R, Evans DG et al.
(
2020
)
.
505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
.
International Journal of Gynecological Cancer
.
Conference:
Prevention of gynaecologic cancer
vol.
30
,
a93
-
a94
.
Gaba F, Marks D, Saridogan E, Mccluggage WG, Hanson H, Singh N, Legood R, Evans DG et al.
(
2020
)
.
507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study
.
International Journal of Gynecological Cancer
.
Conference:
Prevention of gynaecologic cancer
vol.
30
,
a94
-
a94
.
Gallagher A, Waller J, Manchanda R, Jacobs I, Sanderson S
(
2020
)
.
Women’s Intentions to Engage in Risk-Reducing Behaviours after Receiving Personal Ovarian Cancer Risk Information: An Experimental Survey Study
.
Cancers
vol.
12
,
(
12
)
Krämer P, Grube M, Renno T, Brar H, McAlpine J, de Kroon C, Heitz F, Heublein S et al.
(
2020
)
.
454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD)
.
Conference:
Postera188.2
-
a1a189
.
Krämer P, Talhouk A, Brett MA, Chiu DS, Cairns ES, Scheunhage DA, Hammond RFL, Farnell D et al.
(
2020
)
.
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
.
Clinical Cancer Research
vol.
26
,
(
20
)
5400
-
5410
.
Grube M, Krämer P, Chiu D, Bosse T, Scheunhage D, Koebel M, Singh N, Manchanda R et al.
(
2020
)
.
Immunhistochemische Expression von L1CAM in endometrioiden Ovarialkarzinomen – Ein neuer prognostischer Marker?
.
Geburtshilfe und Frauenheilkunde
.
Conference:
Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)
vol.
80
,
Gaba F, Robbani S, Singh N, McCluggage WG, Wilkinson N, Ganesan R, Bryson G, Rowlands G et al.
(
2020
)
.
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial
.
International Journal of Gynecological Cancer
vol.
31
,
(
2
)
286
-
291
.
Gaba F, Blyuss O, Chandrasekaran D, Osman M, Goyal S, Gan C, Izatt L, Tripathi V et al.
(
2020
)
.
Attitudes towards risk‐reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
128
,
(
4
)
714
-
726
.
Evans O, Manchanda R
(
2020
)
.
Population-based Genetic Testing for Precision Prevention
.
Cancer Prevention Research
vol.
13
,
(
8
)
643
-
648
.
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, De Freitas Lopes AC, Gaba F, Brentnall A et al.
(
2020
)
.
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
.
Cancers
vol.
12
,
(
7
)
Gentry-Maharaj A, Blyuss O, Ryan A, Burnell M, Karpinskyj C, Gunu R, Kalsi JK, Dawnay A et al.
(
2020
)
.
Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
.
Cancers
vol.
12
,
(
7
)
Gaba F, Blyuss O, Liu X, Goyal S, Lahoti N, Chandrasekaran D, Kurzer M, Kalsi J et al.
(
2020
)
.
Population study of ovarian cancer risk prediction for targeted screening and prevention
.
Cancers
vol.
12
,
(
5
)
Manchanda R, Buist DSM, Evans DGR
(
2020
)
.
Future Research Suggestions for Multigene Testing in Unselected Populations—Reply
.
JAMA Oncology
vol.
6
,
(
5
)
785
-
786
.
Manchanda R, Lieberman S, Gaba F, Lahad A, Levy-Lahad E
(
2020
)
.
Population Screening for Inherited Predisposition to Breast and Ovarian Cancer
.
Annual Review of Genomics and Human Genetics
vol.
21
,
(
1
)
1
-
40
.
Manchanda R
(
2020
)
.
Advances in the screening and prevention of Women's cancers
.
Best Practice and Research: Clinical Obstetrics and Gynaecology
vol.
65
,
1
-
2
.
Evans O, Gaba F, Manchanda R
(
2020
)
.
Population-based genetic testing for Women's cancer prevention
.
Best Practice & Research Clinical Obstetrics & Gynaecology
vol.
65
,
139
-
153
.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.
(
2020
)
.
Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448]
.
Gynecologic Oncology
vol.
157
,
(
2
)
558
-
559
.
Gaba F, Manchanda R
(
2020
)
.
Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers
.
Best Practice and Research: Clinical Obstetrics and Gynaecology
vol.
65
,
46
-
65
.
Casey L, Powell A, Bohm S, Manchanda R, Lockley M, Kobel M, Singh N
(
2020
)
.
Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy
.
LABORATORY INVESTIGATION
.
vol.
100
,
1024
-
1024
.
Gaba F, Chandrasekaran D, Menon U, Evans G, Singh N, McCluggage G, Wilkinson N, Ganesan R et al.
(
2019
)
.
EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study
.
International Journal of Gynecological Cancer
.
Conference:
ePoster Talks: Ovarian + Endometria
vol.
29
,
Gaba F, Liu X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Menon U, Jacobs I et al.
(
2019
)
.
EP1231 Impact of population genetic testing and ovarian cancer risk stratification on the emotional well-being and health of unselected women in a general population
.
International Journal of Gynecological Cancer
.
Conference:
ePoster Talks: Ovarian + Endometria
vol.
29
,
Sundar S, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al.
(
2019
)
.
EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study
.
International Journal of Gynecological Cancer
.
Conference:
ePoster
vol.
29
,
Daia M, Chandrasekaran D, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A, Phadnis S
(
2019
)
.
EP1332 Follow the yellow brick road – Supra-renal para-aortic lymphadenectomy for metastatic ovarian cancer
.
International Journal of Gynecological Cancer
.
Conference:
Cinema Viewing
vol.
29
,
Gaba F, Farrag A, Lawrence A, Brockbank E, Jeyarajah A, Manchanda R, Phadnis S
(
2019
)
.
EP1342 Ovarian cancer with metastatic inguinal lymphadenopathy: an abdominal approach to inguinal nodes dissection
.
International Journal of Gynecological Cancer
.
Conference:
Cinema Viewing
vol.
29
,
Dokmeci A, Abdurrayman M, Drymiotou S, Chandrasekaran D, Rai N, Dilley J, Phadnis S, Manchanda R et al.
(
2019
)
.
EP507 Has the robot been beneficial to endometrial cancer patients? A prospective quality improvement project at a london gynae-oncology tertiary centre
.
International Journal of Gynecological Cancer
.
Conference:
ePoster
vol.
29
,
Drymiotou S, Dokmeci A, Chandrasekaran D, Dilley J, Rai N, Lawrence A, Manchanda R, Phadnis S et al.
(
2019
)
.
EP510 Robotic surgery: does high body mass index (BMI) matter?
.
International Journal of Gynecological Cancer
.
Conference:
ePoster
vol.
29
,
Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al.
(
2019
)
.
Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing
.
International Journal of Gynecological Cancer
.
Conference:
Best Oral/Late-Breaking Abstracts 4 – Miscellaneous
vol.
29
,
Sun L, Brentnall A, Patel S, Buist D, Bowles E, Evans D, Eccles D, Hopper J et al.
(
2019
)
.
Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
.
International Journal of Gynecological Cancer
.
Conference:
Oral Communication 4 – Gynaecological Cancer
vol.
29
,
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al.
(
2019
)
.
A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer
.
JAMA Oncology
Manchanda R, Sun L, Patel S, Wilschut J, de Freitas ALC, Brentnall A, Duffy S, Cui B et al.
(
2019
)
.
10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing
.
International Journal of Gynecological Cancer
.
Conference:
Plenary sessions
vol.
29
,
Sun L, Brentnall A, Patel S, Buist SM D, Bowles JA E, Evans R DG, Eccles D, Hopper J et al.
(
2019
)
.
66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
.
Regional plenaryA36.2
-
A37
.
Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al.
(
2019
)
.
81 Attitude towards and factors affecting uptake of population based BRCA testing in ashkenazi jews: a cohort study
.
International Journal of Gynecological Cancer
.
Conference:
E-Poster discussions
vol.
29
,
Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al.
(
2019
)
.
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term outcomes
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
127
,
(
3
)
364
-
375
.
Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I et al.
(
2019
)
.
Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results
.
Histopathology
vol.
75
,
(
6
)
813
-
824
.
Tan A, Rivas C, Yorke S, Khan K, Rogozinska E, Brockbank E, Manchanda R, Cooper N
(
2019
)
.
Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)
.
BJOG: an International Journal of Obstetrics and Gynaecology
.
Conference:
RCOG World Congress 2019
vol.
126
,
85
-
85
.
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.
(
2019
)
.
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
.
Gynecologic Oncology
Cohen P, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al.
(
2019
)
.
Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data
.
Gynecologic Oncology
Crosbie E, MANCHANDA R, Manchester International Consensus Group
(
2019
)
.
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome
.
Genetics in Medicine
GABA F, Piek J, Menon U, MANCHANDA R
(
2019
)
.
Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary
.
BJOG: An International Journal of Obstetrics and Gynaecology
MANCHANDA R, GABA F
(
2019
)
.
A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm
.
BJOG: An International Journal of Obstetrics and Gynaecology
Koutoukidis D, Beeken R, MANCHANDA R, Burnell M, Ziauddeen N, Michalopoulou M, Knobf MT, Lanceley A
(
2019
)
.
Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial
.
International Journal of Gynecological Cancer
vol.
29
,
(
3
)
MANCHANDA R, Matthew B, GABA F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al.
(
2019
)
.
Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study
.
BJOG: An International Journal of Obstetrics and Gynaecology
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N
(
2019
)
.
Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets)
.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
.
vol.
126
,
82
-
82
.
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N
(
2019
)
.
Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)
.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
.
vol.
126
,
84
-
84
.
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N
(
2019
)
.
Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)
.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
.
vol.
126
,
86
-
87
.
Osman M, Chandrasekaran D, Musa E, Afnan-Holmes H, Brockbank E, Lawrence A, Manchanda R
(
2018
)
.
Evaluation of the diagnostic hysteroscopy service in gynaecology oncology
.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
.
Conference:
National Trainees Conference 2018
vol.
125
,
24
-
24
.
MANCHANDA R, GABA F
(
2018
)
.
Population Based Testing for Primary Prevention:
A Systematic Review
.
Cancers
Puntambekar S, MANCHANDA R
(
2018
)
.
Surgical pelvic anatomy in gynecologic oncology
.
International Journal of Gynecology and Obstetrics
vol.
143
,
86
-
92
.
Manchanda R, Gaba F
(
2018
)
.
Population Based Testing for Primary Prevention: A Systematic Review
.
MANCHANDA R, Legood R
(
2018
)
.
Population based germline testing for primary cancer prevention
.
Oncotarget
vol.
9
,
(
69
)
33062
-
33063
.
Vazquez MA, Marino IP, BLYUSS O, Ryan A, GENTRY-MAHARAJ A, Kalsi J, MANCHANDA R, Jacobs I et al.
(
2018
)
.
A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer
.
Biomedical Signal Processing and Control
BLYUSS O, Burnell M, Ryan A, GENTRY-MAHARAJ A, Marino I, Kalsi J, MANCHANDA R, Timms JF et al.
(
2018
)
.
Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population
.
Clinical Cancer Research
Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ et al.
(
2018
)
.
Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities
.
Gynecologic Oncology Reports
Mariño IP, Vázquez MA, Blyuss O, Ryan A, Gentry-Maharaj A, Kalsi J, Manchanda R, Jacobs I et al.
(
2018
)
.
Diagnosis of ovarian cancer based on longitudinal measurements of multiple biomarkers
.
Opera Medica et Physiologica
vol.
4
,
71
-
72
.
Crusz SM, Chandrasekaran D, Phadnis S, Delvin MJ, Quigley M, Powell ME, Jeyarajah A, Oram D et al.
(
2018
)
.
Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC)
.
Journal of Clinical Oncology
.
vol.
36
,
e17530
-
e17530
.
Chandrasekaran D, Manchanda R
(
2018
)
.
Germline & somatic genetic testing in ovarian cancer patients
.
BJOG
Yang X, Leslie G, Gentry-Maharaj A, Ryan A, Intermaggio M, Lee A, Kalsi JK, Tyrer J et al.
(
2018
)
.
Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study
.
Journal of Medical Genetics
vol.
55
,
(
8
)
Chandrasekaran D, Gaba F, Manchanda R
(
2018
)
.
Preinvasive Disease, Screening and Hereditary Cancer
.
Gynaecological Oncology for the MRCOG
,
Cambridge University Press (CUP)
Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Gan C, Taylor R et al.
(
2018
)
.
Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population
.
Journal of Medical Genetics
vol.
55
,
(
8
)
Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ et al.
(
2018
)
.
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
.
Journal of the National Cancer Institute
vol.
110
,
(
7
)
714
-
725
.
Jiang J, Phadnis S, Miller R, Powell M, Sahdev A, Singh N, Lawrence A, Brockbank E et al.
(
2018
)
.
DISTANT RECURRENCES ARE COMMON FOLLOWING PELVIC EXENTERATION FOR MALIGNANCY OF NON-CERVICAL ORIGIN
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
28
,
963
-
963
.
Jiang J, Phadnis S, Miller R, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A
(
2018
)
.
OUTCOMES OF BOWEL RESECTIONS DURING SURGICAL CYTOREDUCTION OF ADVANCED STAGE OVARIAN CANCER: SHOULD WE BE WORKING TOWARDS REDUCING STOMA RATES?
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
28
,
719
-
719
.
Singh N, Piskorz A, Bosse T, Jimenez-Linan M, Jeyarajah A, Manchanda R, Gilks CB, Brenton J et al.
(
2018
)
.
P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
28
,
565
-
565
.
Sundar S, Kumar S, Long J, Balega J, Fotopoulou C, Broadhead T, Duncan T, Morrison J et al.
(
2018
)
.
PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
28
,
604
-
606
.
Farrag A, Light M, Sahdev A, Singh N, Brockbank E, Manchanda R, Phadnis S
(
2018
)
.
SOLITARY RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE CERVIX IN THE OMENTUM - MANAGEMENT OF AN UNUSUAL PRESENTATION
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
28
,
366
-
366
.
Patel S, Legood R, Evans DG, Turnbull C, Antoniou AC, Menon U, Jacobs I, Manchanda R
(
2017
)
.
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women
.
American Journal of Obstetrics and Gynecology
vol.
218
,
(
4
)
431.e1
-
431.e12
.
MANCHANDA R, Menon U
(
2017
)
.
Setting the threshold for surgical prevention in women at increased risk of ovarian cancer
.
International Journal of Gynecological Cancer
Meisel SF, Freeman M, Waller J, Fraser L, Gessler S, Jacobs I, Kalsi J, Rahman B et al.
(
2017
)
.
Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study
.
BMC Public Health
vol.
17
,
Article
882
,
Koutoukidis DA, Beeken RJ, Manchanda R, Michalopoulou M, Burnell M, Knobf MT, Lanceley A
(
2017
)
.
Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial
.
BMJ Open
vol.
7
,
(
10
)
Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ et al.
(
2017
)
.
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
.
American Journal of Obstetrics and Gynecology
vol.
217
,
(
5
)
578.e1
-
578.e12
.
Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR et al.
(
2017
)
.
Persistence of fimbrial tissue on the ovarian surface after salpingectomy
.
American Journal of Obstetrics and Gynecology
vol.
217
,
(
4
)
425.e1
-
425.e16
.
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.
(
2017
)
.
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
.
Obstetrical & Gynecological Survey
vol.
72
,
(
6
)
338
-
340
.
Bansal JK, Goldrick IG, Manchanda R, Olaitan A
(
2017
)
.
Rapid-access gynecological oncology clinic outcomes in North London, UK
.
Clinical Audit
vol.
9
,
19
-
23
.
MANCHANDA R, Legood R, Antoniou AC, Pearce L, Menon U
(
2017
)
.
Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer
.
BJOG: An International Journal of Obstetrics and Gynaecology
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al.
(
2017
)
.
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
.
J Clin Oncol
vol.
35
,
(
13
)
1411
-
1420
.
Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L
(
2017
)
.
Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges
.
Gynecologic Oncology Reports
vol.
20
,
9
-
14
.
Manchanda R
(
2017
)
.
Opportunistic salpingectomy for prevention of ovarian cancer
.
BJOG: An International Journal of Obstetrics and Gynaecology
vol.
124
,
(
6
)
890
-
890
.
Gan C, Bossart M, Piek J, Halaska M, Haidopoulos D, Zapardiel I, Grabowski JP, Kesic V et al.
(
2017
)
.
Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees
.
International Journal of Gynecological Cancer
vol.
27
,
(
2
)
375
-
381
.
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A
(
2017
)
.
Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1
.
Trials
vol.
18
,
(
1
)
28
-
28
.
Gaba FM, Manchanda R, Gaba FM, Manchanda R
(
2017
)
.
Genetic testing for gynaecological cancer
.
Obstetrics, Gynaecology and Reproductive Medicine
vol.
27
,
(
1
)
29
-
31
.
Manchanda R, Gaba F, Bottla K, Mousa K, Burnell M, Kalsi J, Gentry-Maharaj A, Antoniou A et al.
(
2017
)
.
PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS)
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
27
,
1944
-
1944
.
Pennington M, Gentry-Maharaj A, Karpinskyj C, Miners A, Taylor J, Manchanda R, Iyer R, Griffin M et al.
(
2016
)
.
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
.
PLoS One
vol.
11
,
(
11
)
Article
0165539
,
e0165539
-
e0165539
.
La Russa M, Biliatis I, Brockbank E, Faruki A, Lawrence A, Manchanda R, Singh N, Jeyarajah A
(
2016
)
.
CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
Conference:
16th biennial International Gynecologic Cancer Society (IGCS) meeting
(
Lisbon, Portugal
)
from:
29/10/2016
to:
31/10/2016
,
vol.
26
,
1013
-
1013
.
Manchanda R, Gordeev V, Antoniou A, Smith S, Lee A, Hopper J, Macinnis R, Paul P et al.
(
2016
)
.
Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
Conference:
16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016)
vol.
26
,
59
-
60
.
Kumar S, Long J, Rudge G, Manchanda R, Fotopoulou C, Wood N, Duncan T, Balega J et al.
(
2016
)
.
SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
Conference:
16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal
(
Lisbon, Portugal
)
from:
29/10/2016
to:
31/10/2016
,
vol.
26
,
832
-
833
.
Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens AL, Cibula D, Bookman MA et al.
(
2016
)
.
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report
.
International Journal of Gynecological Cancer
vol.
26
,
(
6
)
1186
-
1188
.
Manchanda R, Legood R, Antoniou AC, Gordeev VS, Menon U
(
2016
)
.
Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis
.
Journal of Medical Genetics
vol.
53
,
(
9
)
Manchanda R, Cibula D
(
2016
)
.
Ovarian Cancer Screening There May Be Light at the End of the Tunnel?
.
Int J Gynecol Cancer
vol.
26
,
(
4
)
608
-
609
.
Burnell M, Iyer R, Gentry‐Maharaj A, Nordin A, Liston R, Manchanda R, Das N, Gornall R et al.
(
2016
)
.
Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
123
,
(
13
)
2171
-
2180
.
Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L et al.
(
2016
)
.
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations
.
Journal of Medical Genetics
vol.
53
,
(
7
)
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A
(
2016
)
.
Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: study protocol for a randomized controlled trial
.
Trials
vol.
17
,
(
1
)
MANCHANDA R, Menon U
(
2016
)
.
Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial
FOR: There is lack of clarity on a number of key issues
.
BJOG: an International Journal of Obstetrics and Gynaecology
vol.
123
,
(
3
)
463
-
463
.
Phadnis S, Vali S, Oram D, Lawrence A, Manchanda R, Jeyarajah A, Brockbank E
(
2016
)
.
Enhanced recovery after major gynaecological oncology surgery: Are we meeting the standards?
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
26
,
924
-
924
.
Phadnis S, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E
(
2016
)
.
Morbidity and mortality following major surgery for gynaecological malignancy: A prospective observational study from a cancer centre in London
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
26
,
925
-
925
.
Manchanda R, Chandrasekaran D, Saridogan E, Burnell M, Crawford R, Brockbank E, Kalsi J, Jurkovic D et al.
(
2016
)
.
Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial?
.
International Journal of Gynecological Cancer
vol.
26
,
(
1
)
Manchanda R, Legood R, Antoniou A, Gordeev V, Menon U
(
2016
)
.
Specifying the threshold of 'ovarian cancer risk' for undertaking risk reducing surgery for ovarian cancer prevention in premenopausal women
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
26
,
767
-
767
.
Phadnis S, Korompelis P, Iamprou C, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E
(
2016
)
.
Surgical and oncological outcome of morbidly obese (BMI > 40) women having laparoscopic surgery for early stage endometrial cancer
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
26
,
1057
-
1057
.
Blyuss KB, MANCHANDA R, Kurths J, Alsaedi A, Zaikin A
(
2016
)
.
Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks
.
Computational and Mathematical Methods in Medicine
vol.
2016
,
Article
7904693
,
Dilley J, Manchanda R, Johnson M, Rosenthal AN, Gessler S, Menon U
(
2015
)
.
Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients
.
International Journal of Gynecology & Obstetrics
vol.
133
,
(
2
)
239
-
240
.
Manchanda R, Jacobs I
(
2015
)
.
Genetic screening for gynecological cancer: where are we heading?
.
Future Oncology
vol.
12
,
(
2
)
207
-
220
.
Manchanda R, Legood R, Pearce L, Menon U
(
2015
)
.
Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women
.
Gynecologic Oncology
vol.
139
,
(
3
)
487
-
494
.
Manchanda R
(
2015
)
.
Abstract IS01: Brca testing in high-risk populations
.
Clinical Cancer Research
.
vol.
21
,
is01
-
is01
.
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.
(
2015
)
.
Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK
.
Familial Cancer
vol.
14
,
(
4
)
521
-
530
.
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al.
(
2015
)
.
Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK
.
Familial Cancer
vol.
14
,
(
4
)
521
-
530
.
Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF et al.
(
2015
)
.
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
.
Journal of Medical Genetics
vol.
52
,
(
7
)
Manchanda R, Refaie A
(
2015
)
.
Acute pneumoperitoneum following coitus
.
Canadian Journal of Emergency Medicine
vol.
7
,
(
1
)
51
-
53
.
Manchanda R, Loggenberg K, Burnell M, Wardle J, Sanderson S, Gessler S, Side L, Balogun N et al.
(
2015
)
.
A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
25
,
48
-
49
.
Manchanda R, Legood R, Pearce L, Menon U
(
2015
)
.
DEFINING THE RISK THRESHOLD FOR RISK REDUCING SALPINGO-OOPHORECTOMY FOR OVARIAN CANCER PREVENTION IN LOW RISK POSTMENOPAUSAL WOMEN
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
25
,
600
-
601
.
Karpinskyj CL, Taylor J, Lewis D, Keller C, Pennington M, Ryan A, Manchanda R, Iyer R et al.
(
2015
)
.
QUALITY OF LIFE IN ENDOMETRIAL CANCER SURVIVORS - A COHORT STUDY NESTED WITHIN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS)
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
25
,
610
-
611
.
Piek J, Bossart M, Boor K, Halaska M, Haidopoulos D, Zapardiel I, Grabowski J, Kesic V et al.
(
2015
)
.
The Work Place Educational Climate in Gynecological Oncology Fellowships Across Europe
.
International Journal of Gynecological Cancer
vol.
25
,
(
1
)
180
-
190
.
Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R et al.
(
2014
)
.
Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications)
.
British Journal of Cancer
vol.
112
,
(
3
)
475
-
484
.
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S et al.
(
2014
)
.
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
.
Journal of the National Cancer Institute
vol.
107
,
(
1
)
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al.
(
2014
)
.
Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial
.
Journal of the National Cancer Institute
vol.
107
,
(
1
)
Manchanda R, Menon U
(
2014
)
.
Serum markers for gynaecological cancer in the reproductive years
.
Cancer and Reproductive Health
,
Cambridge University Press (CUP)
Kalsi JK, Manchanda R, Menon U
(
2014
)
.
Screening for gynecological cancers
.
Expert Review of Obstetrics & Gynecology
vol.
8
,
(
2
)
143
-
160
.
Manchanda R, Sanderson S, Loggenberg K, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al.
(
2014
)
.
POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
24
,
30
-
31
.
Manchanda R, Legood R, Burnell M, McGuire A, Loggenberg K, Wardle J, Sanderson S, Gessler S et al.
(
2014
)
.
POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
vol.
24
,
(
9
)
470
-
471
.
Manchanda R, Gessler S, Loggenberg K, Sanderson S, Burnell M, Wardle J, Side L, Balogun N et al.
(
2014
)
.
Population Testing for Inherited, Cancer Predisposing BRCA 1 and BRCA2 Founder Mutations in the Ashkenazi Jewish Community in London: The Psychological Impact on Participants of a Randomised Controlled Trial
.
PSYCHO-ONCOLOGY
.
vol.
23
,
120
-
121
.
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al.
(
2013
)
.
Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2)
.
Journal of Clinical Oncology
vol.
31
,
(
15_suppl
)
5507
-
5507
.
Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, Gultekin M, Vranes B et al.
(
2013
)
.
The Need for More Workshops in Laparoscopic Surgery and Surgical Anatomy for European Gynaecological Oncology Trainees: A Survey by the European Network of Young Gynaecological Oncologists
.
International Journal of Gynecological Cancer
vol.
23
,
(
6
)
Philpott S, Rizzuto I, Fraser L, Manchanda R, Hadwin R, Burnell M, Mackay S, Skates S et al.
(
2013
)
.
DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS)
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
vol.
23
,
(
8
)
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al.
(
2013
)
.
Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2)
.
JOURNAL OF CLINICAL ONCOLOGY
.
vol.
31
,
Manchanda R, Legood R, Burnell M, McGuire A, Legood R, Loggenberg K, Wardle J, Sanderson S et al.
(
2013
)
.
POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
23
,
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al.
(
2013
)
.
RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2)
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
vol.
23
,
(
8
)
Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH et al.
(
2012
)
.
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
.
Journal of Clinical Oncology
vol.
31
,
(
1
)
49
-
57
.
Manchanda R, Godfrey M, Wong-Taylor LA, Halaska MJ, Burnell M, Grabowski JP, Gultekin M, Haidopoulos D et al.
(
2012
)
.
The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO)
.
Annals of Oncology
vol.
24
,
(
4
)
944
-
952
.
Manchanda R, Drapkin R, Menon U
(
2012
)
.
There is a need for routine peritoneal cytology at RRSO
.
Gynecologic Oncology
vol.
128
,
(
1
)
149
-
150
.
Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Side L et al.
(
2012
)
.
Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS)
.
Archives of Gynecology and Obstetrics
vol.
286
,
(
6
)
1555
-
1562
.
Brantnerova R, Manchanda R, Colombo N
(
2012
)
.
The European Society of Gynaecological Oncology: Update on Objectives and Educational and Research Activities
.
American Society of Clinical Oncology Educational Book
(
32
)
335
-
338
.
Fourkala EO, Gentry-Maharaj A, Burnell M, Ryan A, Manchanda R, Dawnay A, Jacobs I, Widschwendter M et al.
(
2012
)
.
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
.
British Journal of Cancer
vol.
106
,
(
12
)
1910
-
1916
.
Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A
(
2012
)
.
International Conference on Ovarian Cancer Screening
.
International Journal of Gynecological Cancer
vol.
22
,
(
&NA;
)
Gentry-Maharaj A, Kalsi J, Burnell M, Manchanda R, Menon U
(
2012
)
.
Screening of symptomatic women for ovarian cancer
.
The Lancet Oncology
vol.
13
,
(
4
)
e138
-
e139
.
Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E et al.
(
2012
)
.
Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
119
,
(
5
)
527
-
536
.
Manchanda R, Silvanto A, Abdelraheim A, Burnell M, Johnson M, Saridogan E, Rosenthal AN, Brunell C et al.
(
2012
)
.
Diathermy-Induced Injury May Affect Detection of Occult Tubal Lesions at Risk-Reducing Salpingo-Oophorectomy
.
International Journal of Gynecological Cancer
vol.
22
,
(
5
)
Manchanda R, Loggenberg K, Gessler S, Sanderson S, Balogun N, Wardle J, Tomlinson I, McGuire A et al.
(
2012
)
.
Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS
.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
.
vol.
22
,
S42
-
S43
.
Vaes E, Manchanda R, Autier P, Nir R, Nir D, Bleiberg H, Robert A, Menon U
(
2011
)
.
Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer‐aided diagnostic tool
.
Ultrasound in Obstetrics and Gynecology
vol.
39
,
(
1
)
91
-
98
.
Manchanda R, Drapkin R, Jacobs I, Menon U
(
2011
)
.
The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer
.
Gynecologic Oncology
vol.
124
,
(
2
)
185
-
191
.
(
2011
)
.
Cross-sectional imaging
.
An Atlas of Gynecologic Oncology
,
Taylor & Francis
Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JMJ, Manchanda R et al.
(
2011
)
.
Gynecologic Oncology Training Systems in Europe: A Report From the European Network of Young Gynaecological Oncologists
.
International Journal of Gynecological Cancer
vol.
21
,
(
8
)
Manchanda R, Abdelraheim A, Johnson M, Rosenthal A, Benjamin E, Brunell C, Burnell M, Side L et al.
(
2011
)
.
Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
118
,
(
7
)
814
-
824
.
Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Autier P, Menon U, Robert A
(
2011
)
.
Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses
.
International Journal of Gynecological Cancer
vol.
21
,
(
1
)
35
-
43
.
Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW et al.
(
2010
)
.
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
.
The Lancet Oncology
vol.
12
,
(
1
)
38
-
48
.
Shafi MI, Earl HM, Tan LT, Manchanda R, Jacobs IJ
(
2010
)
.
Screening and prevention of gynaecological cancers
.
Gynaecological Oncology
,
Cambridge University Press (CUP)
Pichert G, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al.
(
2010
)
.
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers
.
Familial Cancer
vol.
9
,
(
3
)
313
-
319
.
Izatt L, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al.
(
2010
)
.
Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers
.
JOURNAL OF MEDICAL GENETICS
.
vol.
47
,
S116
-
S116
.
Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Robert A, Menon U
(
2009
)
.
1329 A sequential use of the Risk of Malignancy Index and Ovarian HistoScanning for the differential diagnosis of adnexal masses
.
European Journal of Cancer Supplements
vol.
7
,
(
2
)
Manchanda R, Sriemevan A
(
2009
)
.
Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta
.
Journal of Obstetrics and Gynaecology
vol.
25
,
(
2
)
201
-
202
.
Manchanda R, Palep-singh M, Prentice A
(
2009
)
.
Can uterine artery embolisation affect endometrial perfusion and function
.
Journal of Obstetrics and Gynaecology
vol.
28
,
(
2
)
246
-
248
.
Manchanda R, Rosenthal A, Burnell M, Fraser L, Mackay J, Skates S
(
2009
)
.
Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers
.
Journal of Medical Genetics
vol.
46
,
(
6
)
Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I
(
2009
)
.
Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective
.
Current Opinion in Obstetrics & Gynecology
vol.
21
,
(
1
)
31
-
38
.
Manchanda R, Baldwin P, Crawford R, Vowler S, Moseley R, Latimer J, Welton K, Shafi M
(
2008
)
.
Is close follow up feasible for high‐risk cervical premalignant lesion in developing countries?
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
116
,
(
1
)
125
-
126
.
Kriplani A, Agarwal N, Parul, Sharma MC, Manchanda R
(
2008
)
.
Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis
.
Journal of Obstetrics and Gynaecology Research
vol.
29
,
(
2
)
63
-
66
.
Manchanda R, Baldwin P, Crawford R, Vowler S, Moseley R, Latimer J, Welton K, Shafi M
(
2008
)
.
Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
115
,
(
10
)
1238
-
1242
.
MANCHANDA R, KRIPLANI A
(
2005
)
.
Giant malignant ovarian tumor: a case report
.
International Journal of Gynecological Cancer
vol.
15
,
(
6
)
1135
-
1137
.
Manchanda R, Varma R, Anya I, Ting JYS
(
2004
)
.
Representation of authors and editors from poor countries [1] (multiple letters)
.
British Medical Journal
vol.
329
,
(
7457
)
110
-
111
.
Manchanda R, Varma R
(
2004
)
.
Representation of authors and editors from poor countries: Observed publication bias may reflect who is funding research
.
The BMJ
vol.
329
,
(
7457
)
Kriplani A, Manchanda R, Nath J, Takkar D
(
2002
)
.
A randomized trial of danazol pretreatment prior to endometrial resection
.
European Journal of Obstetrics & Gynecology and Reproductive Biology
vol.
103
,
(
1
)
68
-
71
.
Kriplani A, Manchanda R, Agarwal N, Nayar B
(
2001
)
.
Laparoscopic Ovarian Drilling in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome
.
Journal of Minimally Invasive Gynecology
vol.
8
,
(
4
)
511
-
518
.
Kriplani A, Manchanda R, Monga D, Takkar D
(
2001
)
.
Depot Medroxy Progesterone Acetate: A Poor Preparatory Agent for Endometrial Resection
.
Gynecologic and Obstetric Investigation
vol.
52
,
(
3
)
180
-
183
.
Kriplani A, Agarwal N, Roy KK, Manchanda R, Singh MK
(
2001
)
.
Laparoscopic management of Sertoli-Leydig cell tumors of the ovary. A report of two cases
.
The Journal of Reproductive Medicine
vol.
46
,
(
5
)
493
-
496
.